BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25981380)

  • 1. Effectiveness of chemotherapy and radiotherapy for laryngeal preservation in advanced laryngeal cancer: a meta-analysis and systematic review.
    Luo XN; Chen LS; Zhang SY; Lu ZM; Huang Y
    Radiol Med; 2015 Dec; 120(12):1153-69. PubMed ID: 25981380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and
    Wichmann G; Krüger A; Boehm A; Kolb M; Hofer M; Fischer M; Müller S; Purz S; Stumpp P; Sabri O; Dietz A; Kluge R
    Eur J Cancer; 2017 Feb; 72():144-155. PubMed ID: 28033526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following laryngectomy refusal after insufficient response to induction chemotherapy.
    Gorphe P; Matias M; Blanchard P; Even C; Ferte C; Tao Y; Temam S; Bidault F; Janot F
    Laryngoscope; 2017 Aug; 127(8):1791-1796. PubMed ID: 27888508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer.
    Eisbruch A; Thornton AF; Urba S; Esclamado RM; Carroll WR; Bradford CR; Hazuka MB; Littles FJ; Strawderman M; Wolf GT
    J Clin Oncol; 1996 Aug; 14(8):2322-30. PubMed ID: 8708724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
    Dyckhoff G; Plinkert PK; Ramroth H
    BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.
    Stokes WA; Jones BL; Bhatia S; Oweida AJ; Bowles DW; Raben D; Goddard JA; McDermott JD; Karam SD
    Cancer; 2017 Feb; 123(4):600-608. PubMed ID: 27727461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary organ preservation vs total laryngectomy for T4a larynx cancer.
    Oh J; Prisman E; Olson R; Berthelet E; Wu J; Tran E; Bakos B; Kaviani R; Hamilton SN
    Head Neck; 2019 Sep; 41(9):3265-3275. PubMed ID: 31215719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy.
    Al-Mamgani A; Tans L; van Rooij P; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1000-6. PubMed ID: 22099030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ preservation for advanced laryngeal carcinoma.
    Foote RL; Foote RT; Brown PD; Garces YI; Okuno SH; Strome SE
    Head Neck; 2006 Aug; 28(8):689-96. PubMed ID: 16619278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol.
    León X; Valero C; Rovira C; Rodriguez C; López M; García-Lorenzo J; Quer M
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2581-2587. PubMed ID: 28349204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).
    Dietz A; Rudat V; Dreyhaupt J; Pritsch M; Hoppe F; Hagen R; Pfreundner L; Schröder U; Eckel H; Hess M; Schröder M; Schneider P; Jens B; Zenner HP; Werner JA; Engenhardt-Cabillic R; Vanselow B; Plinkert P; Niewald M; Kuhnt T; Budach W; Flentje M
    Eur Arch Otorhinolaryngol; 2009 Aug; 266(8):1291-300. PubMed ID: 18972123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy comparison between primary total laryngectomy and nonsurgical organ-preservation strategies in treatment of advanced stage laryngeal cancer: A meta-analysis.
    Tang ZX; Gong JL; Wang YH; Li ZH; He Y; Liu YX; Zhou XH
    Medicine (Baltimore); 2018 May; 97(21):e10625. PubMed ID: 29794737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
    Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of 849 laryngeal cancers treated in the past 40 years: are we succeeding?
    Nakayama M; Okamoto M; Hayakawa K; Miyamoto S; Ishiyama H; Komori S; Okamoto T; Seino Y; Kano K; Soda I; Sekiguchi A; Kawakami S
    Jpn J Clin Oncol; 2014 Jan; 44(1):57-64. PubMed ID: 24174633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers.
    Nair SV; Mair M; Sawarkar N; Chakrabarti S; Qayyumi B; Nair D; Chaturvedi P; Gupta T; Agrawal JP
    Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2311-2316. PubMed ID: 29959566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
    Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
    Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of postoperative adjuvant radiotherapy for locally advanced laryngeal cancer: a meta-analysis.
    Li M; Zhang T; Tan B; Yu M; Zhang B
    Acta Otolaryngol; 2019 Feb; 139(2):172-177. PubMed ID: 30734627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
    Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
    Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.